DNA repair gene polymorphisms may be associated with prognosis of upper urinary tract transitional cell carcinoma
- PMID: 18320070
- PMCID: PMC2259454
- DOI: 10.1593/neo.07982
DNA repair gene polymorphisms may be associated with prognosis of upper urinary tract transitional cell carcinoma
Abstract
Upper urinary tract transitional cell carcinoma (UUT-TCC) is quite an uncommon disease, and its prognosis differs among individuals irrespective of tumor stage. DNA repair gene polymorphisms are reported to result in the modulation of the repair capacity and might influence the prognosis of UUT-TCC. We examined the associations between functional polymorphisms in five DNA repair genes, and the prognosis of UUT-TCC in 103 UUT-TCC patients. Variant alleles in xeroderma pigmentosum complementation group C, more than three total variant alleles in all DNA repair genes studied and more than two total variant alleles in three nucleotide excision repair genes were independently associated with improved overall and disease-specific survival of UUT-TCC patients in multivariate analysis (P = .0063 and P = .0005 for xeroderma pigmentosum complementation group C, P = .016 and P = .0016 for all genes, and P = .0053 and P = .018 for nucleotide excision repair genes, respectively). These results suggest that some DNA repair gene polymorphisms may preoperatively be valuable as prognostic factors for UUT-TCC beyond tumor stage and grade, helping to provide optimal treatment strategies for individual patients.
Figures


Similar articles
-
[Transitional cell carcinoma of the upper urinary tract new concepts in management].Presse Med. 2005 Apr 23;34(8):601-7. doi: 10.1016/s0755-4982(05)83989-2. Presse Med. 2005. PMID: 15962502 Review. French.
-
Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma.Urology. 2005 Jun;65(6):1233-7. doi: 10.1016/j.urology.2005.01.019. Urology. 2005. PMID: 15922421
-
The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract.Cancer. 2003 Oct 15;98(8):1620-6. doi: 10.1002/cncr.11691. Cancer. 2003. PMID: 14534877
-
Is nephroureterectomy necessary in all cases of upper tract transitional cell carcinoma? Long-term results of conservative endourologic management of upper tract transitional cell carcinoma in individuals with a normal contralateral kidney.Urology. 2001 Aug;58(2):174-8. doi: 10.1016/s0090-4295(01)01109-8. Urology. 2001. PMID: 11489692
-
Imaging and staging of transitional cell carcinoma: part 2, upper urinary tract.AJR Am J Roentgenol. 2009 Jun;192(6):1488-93. doi: 10.2214/AJR.09.2577. AJR Am J Roentgenol. 2009. PMID: 19457809 Review.
Cited by
-
Dinosaurs and ancient civilizations: reflections on the treatment of cancer.Neoplasia. 2010 Dec;12(12):957-68. doi: 10.1593/neo.101588. Neoplasia. 2010. PMID: 21170260 Free PMC article.
-
The War on Cancer rages on.Neoplasia. 2009 Dec;11(12):1252-63. doi: 10.1593/neo.91866. Neoplasia. 2009. PMID: 20019833 Free PMC article.
-
Association of TP53 and MDM2 polymorphisms with survival in bladder cancer patients treated with chemoradiotherapy.Cancer Sci. 2009 Dec;100(12):2376-82. doi: 10.1111/j.1349-7006.2009.01331.x. Epub 2009 Aug 27. Cancer Sci. 2009. PMID: 19764997 Free PMC article.
-
Neoplasia: the second decade.Neoplasia. 2008 Dec;10(12):1314-24. doi: 10.1593/neo.81372. Neoplasia. 2008. PMID: 19048110 Free PMC article.
-
Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC).World J Urol. 2017 Mar;35(3):379-387. doi: 10.1007/s00345-016-1928-x. Epub 2016 Sep 7. World J Urol. 2017. PMID: 27604375 Review.
References
-
- Hall MC, Womack S, Sagalowsky AI, Carmody T, Erickstad MD, Roehrborn CG. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology. 1998;52:594–601. - PubMed
-
- Bamias A, Deliveliotis C, Fountzilas G, Gika D, Anagnostopoulos A, Zorzou MP, Kastritis E, Constantinides C, Kosmidis P, Dimopoulos MA. Adjuvant chemotherapy with paclitaxel and carboplatin in patients with advanced carcinoma of the upper urinary tract: a study by the Hellenic Cooperative Oncology Group. J Clin Oncol. 2004;22:2150–2154. - PubMed
-
- Czito B, Zietman A, Kaufman D, Skowronski U, Shipley W. Adjuvant radiotherapy with and without concurrent chemotherapy for locally advanced transitional cell carcinoma of the renal pelvis and ureter. J Urol. 2004;172:1271–1275. - PubMed
-
- Lerner SE, Blute ML, Richardson RL, Zincke H. Platinum-based chemotherapy for advanced transitional cell carcinoma of the upper urinary tract. Mayo Clin Proc. 1996;71:945–950. - PubMed
-
- Roupret M, Fromont G, Azzouzi AR, Catto JW, Vallancien G, Hamdy FC, Cussenot O. Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma. Urology. 2005;65:1233–1237. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical